Infusion System
By designing an integrated infusion system, the stop function of the welding connection port and the pipe needle can be used to achieve the mixing of drugs and solutions in a sterile environment, solving the problems of complex impurity infiltration and operation in the prior art, improving safety and efficiency.
Patent Information
- Application Number
- CN201880097958.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2018-09-24
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2038-09-24
AI Technical Summary
The prior art is prone to impurities penetration and contamination when mixing powdered or lyophilized drugs with solutions, which increases the risk of patients, and is complex and time-consuming to operate, making it difficult to mix in a sterile environment.
Design an integrated infusion system, including pharmaceutical bottle containers, liquid containers and pipe needles, maintaining a sterile environment through the welding connection port, pipe needles have a stop function and interrupt protrusions to prevent retraction, and verify with hydrogen peroxide chemical indicators Sterile.
A one-step mixing of powdered or liquid drugs in drug bottles with solutions in solution containers under a sterile environment reduces operational complexity and contamination risks, and improves safety and efficiency.
Smart Images

Figure CN112739307B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to an integrated infusion system with an integral structure, in which a medicine bottle of a powdered, freeze-dried or liquid medicine is easily connected to a container containing a solution in a completely sterilized state, so that the powdered, freeze-dried or liquid medicine in the medicine bottle is mixed with the solution in the container through a single contact that can be easily obtained in a short time. Background Art
[0002] When an anticancer drug or a freeze-dried drug in a powdered form or a lyophilized (powder) form is administered to a patient in a clinic or hospital, the powdered drug contained in a container such as a vial is mixed with a certain amount of a solution such as saline and then dripped.
[0003] For instillation, a solution such as saline solution is injected into a bottle with a disposable syringe to dissolve the powdered drug, and then the dissolved solution is transferred to a solution container with another disposable syringe. This method is often used because it does not require additional equipment. However, impurities may infiltrate during this process, which causes great adverse effects and dangers to the patient being treated.
[0004] Another method of administering a powdered form or lyophilized drug is to use a system in which a coupling tool such as a double-ended needle or a coupling tube is used to couple the dissolved drug to a container containing a solution. The container containing the dissolved drug is tilted so that the drug dissolved in the container is added to the container containing the solution.
[0005] However, this operation is complicated and time-consuming. In particular, since the process of punching holes in the container containing the medicine is performed in the air, the possibility of contaminating the medicine is increased. In addition, the possibility of hospital infection caused by the abuse of antibiotic injection is also increased.
[0006] Therefore, there remains a need for a system in which a powdered, freeze-dried or liquid drug in a drug vial can be mixed with a solution in a solution container in a one-step process in a visually confirmed sterile environment that is easily accessible and suitable for use within a short period of time. Summary of the invention
[0007] The present invention provides an integrated infusion system, which comprises: a medicine bottle container suitable for holding a medicine bottle, the medicine bottle container comprising a bottle holder element and a holder cap element, wherein the bottle holder element and the holder cap element are welded together to form a seal; a hydrogen chemical indicator located inside the medicine bottle container for sterility verification; a second container suitable for holding a liquid, the second container comprising a first end and a second end; a welded or sealed connection port connecting the second container and the medicine bottle container, the welded or sealed connection port having a cavity having a protrusion serving as a stopper; a release member disposed at the second end of the second container, the release member being suitable for Release liquid from the second container; a channel (flue, channel, tubular, with channel) needle, which includes a seat and a tip, wherein the tip of the channel needle is suitable for entering the cavity of the fused connection port and punching through the drug bottle in response to pressure applied to the seat of the channel needle; at least three interruption protrusions on the channel needle, which are constructed to be easy to insert and are used to prevent the channel needle from retracting after pressure is applied to the seat of the channel needle to punch through the drug bottle; at least one fixing protrusion on the channel needle, which is suitable for contacting and interacting with a protruding portion inside the cavity of the fused connection port and preventing the channel needle from moving from an initial position in the absence of external force. BRIEF DESCRIPTION OF THE DRAWINGS
[0008] Figures 1A-1D An integrated infusion system according to the invention with some of its components is shown.
[0009] Figures 2A-2H Components of a release member according to the invention are shown.
[0010] Figures 3A-3G An infusion port according to the invention is shown.
[0011] Figures 4A-4G A cap according to the invention is shown.
[0012] Figures 5A-5F An infusion port and a cap according to the invention are shown in an assembled configuration.
[0013] Figure 6A-6B Components of a connecting port assembly according to the present invention are shown.
[0014] Figures 7A-7K A connection port according to the invention is shown.
[0015] Figures 8A-8F A conduit needle according to the invention is shown.
[0016] 9A to 9F A connection port assembly according to the invention is shown comprising a connection port and a channel needle in an assembled configuration.
[0017] Fig.10 Components of a medicine vial container according to the present invention are shown.
[0018] Figures 11A-11G A bottle holder element according to the invention is shown.
[0019] FIG. 12A to FIG. 12G A holder cap element according to the invention is shown.
[0020] FIG. 13A to FIG. 13F A connection port / bottle holder arrangement according to the invention is shown in an assembled configuration.
[0021] FIG. 14A to FIG. 14C Different sizes of bags according to the invention are shown.
[0022] FIG. 15A to FIG. 15C An integrated infusion system according to the invention is shown in an assembled configuration.
[0023] Figures 16A-16C A welded connection port connecting a bottle holder element and a liquid holding bag according to the present invention is shown.
[0024] Figures 17A-17B A tubular ring is shown surrounding the connection between the bottle holder element and the infusion port.
[0025] Fig.18 A holder cap element according to an embodiment is shown welded to a bottle holder element.
[0026] Figures 19A-19B A pharmaceutical vial container with a hydrogen peroxide chemical indicator is shown. DETAILED DESCRIPTION
[0027] The present invention provides an integrated infusion system, which includes: a medicine bottle container for accommodating a medicine bottle; a second container for holding a liquid; and a channel needle that passes through one end of the second container to the medicine bottle container so as to punch a hole through the medicine bottle.
[0028] The fused connection port connects the second container and the medicine bottle container. The fused connection port prevents any contact with the external environment, thereby maintaining a sterile environment inside the medicine bottle container and inside the second container holding the liquid.
[0029] The fused connection port has a cavity, and integral with the shape of the cavity is an internal protruding portion that acts as a stop for the channel needle. The protruding portion is part of the shape or structure of the cavity of the fused connection port. The protruding portion can also control the forward movement of the channel needle.
[0030] The function of the cavity of the connection port as a stopper for the access needle and / or the control of the forward movement of the access needle is related to the design of the access needle. The access needle includes a seat and a tip, wherein the tip of the access needle is adapted to enter the cavity of the welded connection port and punch a hole through the drug vial in response to pressure applied to the seat of the access needle.
[0031] At least one fixing protrusion is arranged on the outer periphery of the channel needle, which is adapted to contact and interact with the protruding portion inside the cavity of the fused connection port and prevent the channel needle from moving from the initial position without external force.
[0032] In addition, there are at least three interruption protrusions on the outer periphery of the channel needle, which are configured to be easily inserted and used to prevent the channel needle from retracting after the pressure applied to the channel needle seat perforates the medicine bottle. In addition, the channel needle is characterized in that at least one interruption protrusion is formed at a position on its outer periphery so that the channel needle stops at a predetermined position in the coupling member after it moves so as not to be further displaced.
[0033] A channel needle is a lumen needle having at least one channel through which a medical solution flows.
[0034] The channel needle is also characterized in that at least one fixing protrusion is formed at a position on the outer periphery thereof so that it is not easily displaced from an initial state without an external force.
[0035] In one embodiment, the conduit needle may also include a mark near the seat of the needle as a visual confirmation of when the needle enters the cavity of the fused connection port and punches through the drug bottle in response to pressure applied to the seat of the conduit needle. The mark will help the operator visually confirm that the needle has been properly inserted and is at the predetermined length of the needle. The mark on the needle can be in the form of a mark at a predetermined length on the needle itself. The mark on the needle can also be displayed in color. For example, a black line or a colored line can appear on the periphery of the needle at a predetermined length from the seat.
[0036] In another embodiment, the cannula needle itself may be a color, so that when the color of the needle is seen through a device according to the present invention, an operator of the syringe will easily visually confirm that the needle has been properly inserted.
[0037] A hydrogen peroxide chemical indicator is located inside the pharmaceutical bottle container. For example, a hydrogen peroxide chemical indicator inside the pharmaceutical bottle container can be inserted and sterilized by VHP (vapor hydrogen peroxide). Internal sterility can be verified by a change in the color of the indicator inside the pharmaceutical bottle container. For example, if the internal environment is no longer sterile, the indicator will change from pink to purple.
[0038] In addition, the medicine bottle container includes a bottle holder element and a holder cap element, wherein the bottle holder element and the holder cap element are fused together to form a seal. The bottle holder element and the holder cap element can be fused together by ultrasonic or thermal welding or any other conventional means. This design further helps to maintain the sterile environment of the integrated infusion system of the present invention.
[0039] The retainer cap element may optionally have a fixed packaging element for holding the medicine bottle in place. In addition, the retainer cap element may also have a hanging device for hanging the medicine bottle container.
[0040] However, no packaging element such as rubber is required at the end of the bottle holder element to secure the drug bottle in place to protect the integrity of the drug bottle's entry point because the welded connection port maintains its sterility and because the thinner neck design portion holds the drug bottle in place.
[0041] Additionally, the medicine bottle can be made of glass or plastic material.
[0042] The integrated infusion system according to the present invention can be manufactured easily and at low cost, since the entire system is compact and the number of parts is greatly reduced, without the risk of contamination from the external environment affecting the entire system.
[0043] In addition, when the second container is a plastic container, the solution in the second container can be easily moved by using a channel needle that is a cavity needle. The medicines in the medicine bottle container and the solution bag can be mixed and easily obtained in a short time.
[0044] FIG. 1 shows components of an integrated infusion system according to the present invention. Figure 1A , 1B 1C shows a syringe kit 1000 , which includes a release member 1010 , a connection port / vial holder device 1020 , and a bag 1030 . Figure 1D Alternative shapes of release members are shown, such as 1010 - 1 and 1010 - 2 .
[0045] FIG. 2 shows the components of a release member 1010 according to the present invention. The release member 1010 includes an infusion port 1125 ( Figure 2F ) and cap 1140( Figure 2A and 2B ),like Figure 2G As shown. Figure 2H In FIG. 1 , an alternative design of the infusion port 1125 is shown in a horizontal side view as 1125-1. Different views of alternative designs of the cap are also shown in FIG. Figure 2C , 2D and 2E is shown as 1140-1.
[0046] FIG. 3 shows an infusion port 1125 according to the present invention. Figure 3A A cross-sectional view of the infusion port 1125 is shown. Figure 3B and 3C A perspective view of the infusion port 1125 is shown. Figure 3D A first end view of the infusion port 1125 is shown. Figure 3E A second end view of the infusion port 1125 is shown. Figure 3F A side view of the infusion port 1125 is shown. Figure 3G Several views of an alternative design of a release member 1010 - 1 with an infusion port 1125 - 1 are shown.
[0047] FIG. 4 shows a cap 1140 according to the present invention. Figure 4A A cross-sectional view of cap 1140 is shown.
[0048] Figure 4B and 4C A perspective view of cap 1140 is shown. Figure 4D A first end view of cap 1140 is shown.
[0049] Figure 4E A second end view of cap 1140 is shown. Figure 4F A side view of cap 1140 is shown. Figure 4G Different views of alternative designs of cap 1140 - 1 are shown.
[0050] FIG. 5 shows a schematic diagram of a device according to the present invention in an assembled configuration. Figure 3A , 3B , 3C, 3D, 3E and 3F infusion ports 1125 and Figure 4A , 4B , 4C, 4D, 4E and 4F. The cap 1140 is assembled to the end of the infusion port 1125.
[0051] The connection port / vial holder device 1020 includes a connection port assembly and a medicine vial container. FIG6 shows the components of a connection port assembly according to the present invention. The connection port assembly 1500 includes a connection port 1510 and a channel needle 1520. Fig. 6A The connection port 1510 and the channel needle 1520 are shown respectively, and Figure 6B The connection port 1510 and the channel needle 1520 are shown in an assembled configuration.
[0052] 7 shows a connection port 1510 according to the present invention. The connection port 1510 has a receiving end 1602 adapted to receive a tube needle (such as tube needle 1520) and a connector end 1605. The connection port may optionally have ribs 1510-2. The ribs 1510-2 prevent the films from contacting each other and forming pinholes during heat fusion. Fig. 7A A cross-sectional view of connection port 1510 is shown. Figure 7B and 7C First and second end views of connection port 1510 are shown Figure 7D-7E A perspective view of connection port 1510 is shown.
[0053] Figure 7F , 7G 7H, 7I, 7J and 7K show different views of alternative designs of connection port 1510-1.
[0054] FIG. 8 shows a channel needle according to the present invention. Fig. 8A A cross-sectional view of channel needle 1520 is shown. Channel needle 1520 includes a tip 1760 and an end 1770. Figure 8B and 8C A perspective view of the channel needle 1520 is shown. Fig.8D A side view of the channel needle 1520 is shown. Fig. 8E An end view of the channel needle 1520 is shown (the tip 1760 is visible here). Fig.8F An end view of tubing needle 1520 is shown (end 1770 is visible here).
[0055] FIG. 9 shows a connection port assembly 1500 including a connection port 1510 - 1 and a channel needle 1520 in an assembled configuration according to the present invention. Fig.9A A cross-sectional view of the connection port assembly 1500 is shown. Fig. 9B and 9C An end view of the connection port assembly 1500 is shown. Fig.9D and 9E A perspective view of the connection port assembly 1500 is shown. Fig.9F A side view of the connection port assembly 1500 is shown.
[0056] Fig.10 Components of a medicine vial container 1900 according to the present invention are shown. The components of the medicine vial container 1900 include a vial holder element 1910, a holder cap element 1920, and a medicine vial 1930. The medicine vial container 1900 is also Fig.10 2 is shown in assembled form.
[0057] The drug bottle 1930 is adapted to hold a selected drug. The drug bottle 1930 fits into and is securely held by the bottle holder element 1910, which is designed with a thinner neck region 1911.
[0058] FIG. 11 shows a bottle holder element 1910 according to the present invention. Fig.11AA perspective view of a vial holder element 1910 is shown. The vial holder element 1910 has a container end 2002 adapted to receive a drug vial (such as drug vial 1930) and a connection end 2005. Fig. 11B An end view of the bottle holder element 1910 is shown. Fig. 11C A perspective view of a cross section of the bottle holder element 1910 is shown.
[0059] Fig.11D A side view of the bottle holder element 1910 is shown. Fig.11E A perspective view of the bottle holder element 1910 is shown. Fig.11F An end view of the bottle holder element 1910 is shown. Fig.11G A side view of the bottle holder element 1910 is shown.
[0060] The holder cap element 1920 is adapted to be assembled onto the bottle holder element 1910. Fig. 12 shows a holder cap element 1920 according to the invention. Fig. 12A A perspective view of the cut-away retainer cap element 1920 is shown. Fig. 12B A cross-sectional view of retainer cap element 1920 is shown. Fig. 12C An end view of retainer cap element 1920 is shown. Fig.12D An end view of retainer cap element 1920 is shown.
[0061] Fig.12E A perspective view of retainer cap element 1920 is shown. Fig.12F A perspective view of retainer cap element 1920 is shown. Figure 12G A side view of a retainer cap element 1920 is shown. The end base of the retainer cap element has a plurality of toothpick-like rods or spikes 1921 that are spaced apart to allow fluidity of airflow during the sterilization process of the medicine bottle container. Alternatively, the end base may have at least two flat pans that cross each other perpendicularly, each having an orifice to allow fluidity of airflow during the sterilization process of the medicine bottle container.
[0062] 13 shows the connection port / bottle holder arrangement 1020 in an assembled configuration according to the present invention. The connection end 2005 of the bottle holder element 1910 is connected to the connector end 1605 of the connection port 1510. Fig.13A A cross-sectional view of the connection port / bottle holder arrangement 1020 is shown. Fig. 13B An end view of the connection port / bottle holder arrangement 1020 is shown. Fig. 13C An end view of the connection port / bottle holder arrangement 1020 is shown. Fig.13D and 13EA perspective view of the connection port / bottle holder arrangement 1020 is shown. Fig.13F A side view of connection port / bottle holder arrangement 1020 is shown. An alternative connection port / bottle holder arrangement 1020 may be assembled using connection port 1510-1.
[0063] Fig.14A , 14B 14C show a bag 1030 of different sizes according to the present invention. Bag 1030 includes volume 2310, first opening 2371 and second opening 2373. Opening 2371 is adapted to receive release member 1010. Opening 2373 is adapted to receive connection port / bottle holder device 1020. Openings 2371 and 2373 are adapted to receive appropriate elements (release member 1010 or connection port / bottle holder device 1020) and are not limited to the arrangement structure provided above.
[0064] FIG. 15 shows the syringe kit 1000 in an assembled configuration. Fig.15A As shown in , the release member 1010 and the connection port / bottle holder arrangement 1020 are securely connected to the bag 1030 via the openings 2371 , 2373 . Fig. 15B Different views of the assembled syringe kit are shown. Fig. 15C An alternative arrangement of a release member 1010 and a connection port / bottle holder arrangement 1020 securely connected to a bag 1030 is shown.
[0065] according to Fig.16A In the present invention shown, the bottle holder element 1910 and the connection port 1510-1 are welded together. Specifically, Fig. 16B The connection end 2005 of the bottle holder element 1910 is shown welded to the connector end 1605 of the connection port 1510 - 1 to form a welded connection 2550 . Fig. 16C The connecting end 2005 of the vial holder element 1910 is shown connected to the connector end 1605 of the connection port 1510, with the tubular ring 2560 sealing the connection. This design not only advantageously reduces the number of parts and thus reduces manufacturing costs, but also maintains the sterility of the entire internal communication between the drug vial container and the second container holding the liquid solution.
[0066] Additionally, the vial holder device 1020 provides 100% sterility of the entire internal drug vial set. This sterility can be confirmed by a hydrogen peroxide chemical indicator that confirms that the interior of the drug vial set is protected from contamination entering the sterile environment.
[0067] according to Fig.17AThe illustrated embodiment shows a perspective view and a top view of a tubular ring 2560 surrounding the connection between the bottle holder element and the connection port. Fig. 16C As shown, the tubular ring is configured to abut against the connection between the bottle holder element and the connection port, thereby further protecting the integrity and sterility of the system according to the present invention. The ring can be made of any material suitable and used in the medical device industry, such as polyvinyl chloride (PVC), polypropylene (PP), polyethylene (PE), polystyrene (PS) and nylon, polyethylene terephthalate (PET), polyimide (PA), polycarbonate (PC), acrylonitrile butadiene (ABS), polyether ether ketone (PEEK) and polyurethane (PU). The most widely used plastic in medical applications is PVC, followed by PE, PP, PS and PET. PVC is most widely used in pre-sterilized disposable medical applications. Fig. 17B A tubular ring is shown surrounding the connection between the vial holder element and the infusion port.
[0068] according to Fig.18 In the illustrated embodiment, the holder cap element 1920 is welded to the bottle holder element 1910 to form a welded joint 2615. This design advantageously reduces the number of parts and therefore reduces manufacturing costs.
[0069] Fig.19A A hydrogen peroxide chemical indicator is shown inside a medicine vial container 1900. Fig.19B A close-up of the hydrogen peroxide chemical indicator is shown.
[0070] Therefore, according to one embodiment, an integrated injectable infusion is provided. The integrated injectable infusion comprises
[0071] In another embodiment, the bottle holder element and the holder cap element are welded by heat sealing, by ultrasonic welding or by an adhesive.
[0072] The foregoing embodiments are exemplary only and should not be construed as limiting the present invention. The description of the present invention is intended to be illustrative rather than limiting the scope of the claims. Within the scope of the present invention, many substitutions, modifications and variations will be apparent to those skilled in the art.
Claims
1. An integrated injectable infusion system, comprising: a medicine vial container adapted to hold a medicine vial, the medicine vial container comprising a vial holder element and a holder cap element, and the vial holder element and the holder cap element are welded together to form a seal; a second container adapted to hold a liquid, the second container comprising a first end and a second end; a fused connection port, the fused connection port connecting the second container and the medicine bottle container, the fused connection port having a cavity; a release member disposed at a second end of the second container, wherein the release member is adapted to release the liquid from the second container; and a conduit needle comprising a seat and a tip, wherein the tip of the conduit needle is adapted to enter the cavity of the welded connection port and punch a hole through the drug vial in response to pressure applied to the seat of the conduit needle; at least three interrupting projections on the port needle, the interrupting projections being configured to facilitate insertion and to prevent the port needle from retracting after the pressure applied to the seat of the port needle punches through the drug vial; and at least one fixing protrusion adapted to contact and interact with a protruding portion inside the cavity of the fused connection port and prevent the conduit needle from moving from an initial position without external force, wherein the release member comprises an infusion port and a release cap, wherein the infusion port comprises an outlet, the outlet being fixed to the second container, the outlet being adapted to prevent liquid from leaking from the second container, a released extended edge being mounted at an inner end of the outlet; and wherein the release cap covers the inner end of the outlet and exposes only the center of the released extended edge; and wherein the retainer cap element comprises an end base having a plurality of toothpick-shaped rods or nails spaced apart to allow fluidity of airflow during the sterilization process of the medicine bottle container, or wherein the retainer cap element comprises an end base having at least two flat discs perpendicularly intersecting each other, each flat disc having an orifice to allow fluidity of airflow during the sterilization process of the medicine bottle container, and The integrated injectable infusion system further includes a tubular ring surrounding the connection between the vial holder element and the welded connection port and configured to further protect the integrity and sterility of the integrated injectable infusion system.
2. The integrated injectable infusion system according to claim 1, wherein: The welded connection port also includes a cavity having a protruding portion to clamp the welded connection port and a bottle holder element.
3. The integrated injectable infusion system of claim 2, wherein the tubular ring surrounds the connection between the bottle holder element and the welded connection port and is configured to further seal and protect the integrity of the integrated injectable infusion system.
4. The integrated injectable infusion system according to claim 1, wherein: The welded connection port and the bottle holder element are welded.
5. The integrated injectable infusion system according to claim 1, wherein: The drug bottle contains a drug selected from the group consisting of antibiotics, anticancer agents, broad-spectrum penicillins, cephalosporins, macrolides, intermediate- and narrow-spectrum penicillins, aminoglycosides, carbenicillin, systemic antifungal agents, antituberculosis agents, antiviral agents, anti-HIV agents, alkylating agents, antimetabolites, vinca alkaloids, antitumor antibiotics, platinum antitumor drugs, and mixtures thereof.
6. The integrated injectable infusion system according to claim 1, wherein: The medicine bottle contains a medicine, and the medicine is an antibiotic or an anticancer agent.
7. The integrated injectable infusion system according to claim 6, wherein: The drug is selected from the group consisting of: acyclovir, amikacin sulfate, amoxicillin, amoxicillin, ampicillin, arbekacin, astramycin, azithromycin, aztreonam, belotecan, bendamustine, carbapenem, capreomycin, carboplatin, carumonam, cefmandoloxil, cefazolin, cefoperazone, cefepime, cefmenoxime, cefmetazole, cefminox, cefodizime, cefonicid, cefoperazone ketone, cefoperazone, cefoperazone, cefuroxime, ceftriaxone, cefotetan, cefotiam, cefoxitin, cefpiramide, cefpirome, cefradine, ceftazidime, ceftizole, ceftizoxime, ceftriaxone, cefuroxime, cilastatin, cisplatin, clarithromycin, clavulanic acid, clindamycin phosphate, colistin sodium mesylate, cyclophosphamide, cytarabine, dacarbazine, dalfopristin, doripenem monohydrate, decitabine , docetaxel, doxorubicin, enocitabine, ertapenem, etapenem, erythromycin lactobionate, etoposide, flumoxil sodium, fludarabine, fluorouracil, fosfomycin sodium, ganciclovir, gemcitabine, gentamicin sulfate, epazote, idarubicin, ifosfamide, imipenem, irinotecan, isopamicin sulfate, latamoxef, lincomycin, mecillinam, melphalan, meropenem, methotrexate, micafungin, Micromycin sulfate, netilmicin, oxaliplatin, paclitaxel, panipenem, betamipron, pemetrexed, piperacillin, piperacillin, piperacillin, quinupristin, sisomicin, sulbactam, sulbenicillin, tazobactam, teicoplanin, thiotepa, ticarcillin, tobramycin, topotecan, sulbactam, vancomycin, vinblastine, vincristine, vinorelbine, voriconazole, pharmaceutically acceptable salts thereof, and mixtures thereof.
8. The integrated injectable infusion system according to claim 6, wherein: The drug is selected from the group consisting of: ceftriaxone, cefmetazole sodium, vancomycin hydrochloride, cefotiam hydrochloride, imipenem monohydrate, cilastatin sodium, cefoperazone sodium, sulbactam sodium, teicoplanin, cefotetan disodium, ceftizoxime sodium, ceftriaxone sodium, cefpiramide sodium, and fosfomycin.
9. The integrated injectable infusion system according to claim 6, wherein: The drug is selected from the group consisting of: ceftriaxone 500 mg, ceftriaxone 1 g, ceftriaxone 2 g, cefmetazole sodium 1 g, cefmetazole sodium 0.5 g, vancomycin hydrochloride 1 g, vancomycin hydrochloride 500 mg, ceftiam hydrochloride 1 g, ceftiam hydrochloride 500 mg, imipenem monohydrate 0.5 g, cilastatin sodium 0.5 g, imipenem monohydrate 250 mg, cilastatin sodium 250 mg, cefoperazone sodium 500 mg, sulbactam sodium 500 mg, teicoplanin 0.2 g, cefotetan disodium 1 g, ceftriaxone sodium 1 g, ceftriaxone sodium 1 g, cefpiramide sodium 1 g, and fosfomycin 1 g.
10. The integrated injectable infusion system according to claim 1, wherein: The number of the interruption protrusions on the channel needle is three.
11. The integrated injectable infusion system according to claim 1, wherein: The retainer cap element also includes a hanging device for the drug vial container.
12. The integrated injectable infusion system according to claim 1, wherein: The channel needle is a cavity needle having at least one channel for a medical solution to flow through.
13. The integrated injectable infusion system according to claim 1, wherein: The outer surface of the channel needle further includes a fixing protrusion adapted to contact with the protruding portion inside the cavity of the fused connection port and prevent the channel needle from moving from an initial position without external force.
14. The integrated injectable infusion system according to claim 1, wherein: The medicine bottle is formed of one of a glass material and a plastic material.
15. The integrated injectable infusion system according to claim 1, wherein: The second container is formed from a plastic material.
16. The integrated injectable infusion system according to claim 1, wherein: The release member comprises: A cover seal is attached to an outer surface of the release cap and is adapted to seal the extended edge of the release.
17. The integrated injectable infusion system according to claim 1, wherein: The bottle holder element and the holder cap element are welded by heat sealing, by ultrasonic welding or by an adhesive.
18. An integrated injectable infusion system comprising: a medicine vial container adapted to hold a medicine vial, the medicine vial container comprising a vial holder element and a holder cap element, and the vial holder element and the holder cap element are welded together to form a seal; a hydrogen peroxide chemical indicator located inside the pharmaceutical bottle container for sterility verification; a second container, the second container being adapted to hold a liquid, the second container comprising a first end and a second end; a fused connection port connecting the second container and the medicine bottle container, the fused connection port having a cavity, the cavity having a protruding portion; a release member disposed at a second end of the second container, wherein the release member is adapted to release the liquid from the second container; and a conduit needle comprising a seat and a tip, wherein the tip of the conduit needle is adapted to enter the cavity of the fused connection port and punch a hole through the drug vial in response to pressure applied to the seat of the conduit needle; at least three interrupting projections on the channel needle, the interrupting projections being configured to facilitate insertion and to prevent the channel needle from retracting after the pressure applied to the seat of the channel needle punches through the drug vial; at least one fixing protrusion adapted to contact and interact with the protruding portion within the cavity of the fused connection port and prevent the conduit needle from moving from an initial position without external force, wherein the medicine bottle contains medicine, which is an antibiotic or an anticancer agent, wherein the release member comprises an infusion port and a release cap, wherein the infusion port comprises an outlet, the outlet being fixed to the second container, the outlet being adapted to prevent liquid from leaking from the second container, a released extended edge being mounted at an inner end of the outlet; and wherein the release cap covers the inner end of the outlet and exposes only the center of the released extended edge; and wherein the retainer cap element comprises an end base having a plurality of toothpick-shaped rods or nails spaced apart to allow fluidity of airflow during the sterilization process of the medicine bottle container, or wherein the retainer cap element comprises an end base having at least two flat discs perpendicularly intersecting each other, each flat disc having an orifice to allow fluidity of airflow during the sterilization process of the medicine bottle container, and The integrated injectable infusion system further includes a tubular ring surrounding the connection between the vial holder element and the welded connection port and configured to further protect the integrity and sterility of the integrated injectable infusion system.
